0.250?mg/L). The median fecal lactoferrin concentration at I-week 0 was 1.88 for many individuals in the induction stage. subcutaneous shot (SC) or placebo every 4?weeks for 52?weeks. The principal endpoint was medical response through M-week 54; supplementary endpoints included medical mucosal and remission therapeutic at M-week 30 and 54. Outcomes Continue Reading